Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by tcdrugson May 05, 2010 12:47am
693 Views
Post# 17063563

fda approval rates

fda approval rates
https://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm127155.htm


"The approval rate for Standard review applications was similar regardless of company size (38% for large vs. 35% for small). However, the difference in approval rate on Priority applications was much more significant (78% for large vs. 48% for small), and accounts for the greater first-cycle success for large companies. Booz Allen speculates that this substantial difference may indicate that smaller companies have more deficiencies in their applications and have difficulty managing the compressed, six-month review timeframe of the Priority review, while larger companies with more resources are better able to respond to FDA concerns and issues in a timely fashion."
<< Previous
Bullboard Posts
Next >>